INDIUM IN -111 PENTETREOTIDE

INDIUM IN -111 PENTETREOTIDE was reported 128 times

INDIUM IN -111 PENTETREOTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIATION EXPOSURE 2 0.1333
1 PLATELET TOXICITY 5 0.0543
2 PITUITARY CANCER METASTATIC 1 0.0526
3 INFERIOR VENA CAVAL OCCLUSION 1 0.0087
4 METASTATIC PAIN 1 0.0074
5 RADIOISOTOPE SCAN ABNORMAL 4 0.0057
6 BLOOD BILIRUBIN ABNORMAL 7 0.0055
7 FALSE POSITIVE LABORATORY RESULT 1 0.0054
8 CARCINOID CRISIS 1 0.0044
9 PLATELET DISORDER 10 0.0040
10 SERUM SEROTONIN INCREASED 1 0.0028
11 HAEMOGLOBIN ABNORMAL 16 0.0025
12 WHITE BLOOD CELL DISORDER 6 0.0022
13 SENSORIMOTOR DISORDER 1 0.0020
14 INTENTIONAL DRUG MISUSE 31 0.0015
15 NEUROENDOCRINE TUMOUR 2 0.0014
16 PANCREATIC PSEUDOCYST 1 0.0013
17 BLOOD CREATININE ABNORMAL 4 0.0012
18 DEVICE RELATED THROMBOSIS 1 0.0010
19 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
20 ILEAL ULCER 1 0.0010
21 HYPOPERFUSION 1 0.0010
22 PANCREATIC NEOPLASM 1 0.0008
23 TONIC CLONIC MOVEMENTS 1 0.0008
24 HAEMATOTOXICITY 7 0.0007
25 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
26 MIXED LIVER INJURY 2 0.0007
27 ORAL MUCOSAL EXFOLIATION 1 0.0007
28 LYMPH NODE PAIN 1 0.0005
29 ACCIDENTAL EXPOSURE 2 0.0005
30 PANCREATITIS NECROTISING 1 0.0004
31 MYELODYSPLASTIC SYNDROME 6 0.0004
32 ORAL FUNGAL INFECTION 1 0.0004
33 LYMPHOPENIA 5 0.0004
34 THERAPEUTIC AGENT TOXICITY 1 0.0003
35 METASTASES TO SPINE 1 0.0003
36 ACUTE MYELOID LEUKAEMIA 4 0.0003
37 EMBOLISM 2 0.0002
38 HEPATIC LESION 1 0.0002
39 OCULAR ICTERUS 1 0.0002
40 METASTASES TO LIVER 4 0.0002
41 WRONG DRUG ADMINISTERED 2 0.0002
42 YELLOW SKIN 1 0.0002
43 APHAGIA 1 0.0002
44 NEUROLOGICAL SYMPTOM 1 0.0002
45 NEOPLASM PROGRESSION 6 0.0002
46 NEUROTOXICITY 3 0.0002
47 ULCER HAEMORRHAGE 1 0.0001
48 HYPERTHERMIA 1 0.0001
49 METASTASES TO BONE 2 0.0001
50 MUCOSAL INFLAMMATION 3 0.0001
51 DIZZINESS POSTURAL 1 0.0001
52 GASTROINTESTINAL PAIN 1 0.0001
53 CHROMATURIA 2 0.0001
54 INJECTION SITE EXTRAVASATION 1 0.0001
55 GENERALISED OEDEMA 1 0.0001
56 ILEUS 1 0.0001
57 JAUNDICE 2 0.0001
58 PALLOR 2 0.0001
59 GINGIVAL BLEEDING 1 0.0001
60 ORAL DISCOMFORT 1 0.0001
61 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
62 DISEASE PROGRESSION 8 0.0001
63 HYPOGLYCAEMIA 3 0.0001
64 MUSCLE TIGHTNESS 1 0.0001
65 FLUSHING 6 0.0001
66 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
67 PARANOIA 1 0.0001
68 COLD SWEAT 1 0.0001
69 LYMPHOCYTE COUNT DECREASED 1 0.0001
70 PRODUCT USE ISSUE 10 0.0001
71 PRESCRIBED OVERDOSE 1 0.0001
72 TASTE DISORDER 1 0.0000
73 INJURY ASSOCIATED WITH DEVICE 1 0.0000
74 BODY TEMPERATURE INCREASED 1 0.0000
75 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
76 FAECES DISCOLOURED 1 0.0000
77 BLOOD PRESSURE DECREASED 3 0.0000
78 INJECTION SITE URTICARIA 1 0.0000
79 DIPLOPIA 1 0.0000
80 SKIN LESION 1 0.0000
81 MEDICATION ERROR 2 0.0000
82 FEELING COLD 1 0.0000
83 THROMBOCYTOPENIA 4 0.0000
84 RED BLOOD CELL COUNT DECREASED 1 0.0000
85 DRUG ADMINISTRATION ERROR 1 0.0000
86 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
87 HYPERHIDROSIS 4 0.0000
88 BLOOD CREATININE INCREASED 2 0.0000
89 HEART RATE INCREASED 3 0.0000
90 CHEST DISCOMFORT 3 0.0000
91 HAEMATURIA 1 0.0000
92 GASTRIC DISORDER 1 0.0000
93 HYPERGLYCAEMIA 1 0.0000
94 DISORIENTATION 1 0.0000
95 DEATH 21 0.0000
96 INTENTIONAL PRODUCT MISUSE 2 0.0000
97 TACHYCARDIA 2 0.0000
98 ABDOMINAL PAIN 5 0.0000
99 PYREXIA 7 0.0000
100 ERYTHEMA 4 0.0000
101 MUSCULOSKELETAL PAIN 1 0.0000
102 NAUSEA 15 0.0000
103 ANAPHYLACTIC REACTION 1 0.0000
104 URTICARIA 3 0.0000
105 NECK PAIN 1 0.0000
106 BLISTER 1 0.0000
107 FLATULENCE 1 0.0000
108 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
109 DYSPHONIA 1 0.0000
110 THERAPEUTIC RESPONSE DECREASED 1 0.0000
111 FEELING HOT 1 0.0000
112 INJECTION SITE ERYTHEMA 2 0.0000
113 RHINORRHOEA 1 0.0000
114 INJECTION SITE PRURITUS 1 0.0000
115 ABDOMINAL PAIN UPPER 3 0.0000
116 RESPIRATORY FAILURE 1 0.0000
117 CONDITION AGGRAVATED 4 0.0000
118 BLOOD PRESSURE INCREASED 2 0.0000
119 ACUTE KIDNEY INJURY 2 0.0000
120 BACK PAIN 3 0.0000
121 VOMITING 6 0.0000
122 DRY MOUTH 1 0.0000
123 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
124 SKIN EXFOLIATION 1 0.0000
125 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
126 SUICIDAL IDEATION 1 0.0000
127 OROPHARYNGEAL PAIN 1 0.0000
128 CHEST PAIN 2 0.0000
129 ASTHENIA 4 0.0000
130 DRUG INEFFECTIVE 14 0.0000
131 CONTUSION 1 0.0000
132 SYNCOPE 1 0.0000
133 INJECTION SITE PAIN 3 0.0000
134 HAEMOGLOBIN DECREASED 1 0.0000
135 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
136 ABDOMINAL DISTENSION 1 0.0000
137 PLATELET COUNT DECREASED 1 0.0000
138 DIARRHOEA 6 0.0000
139 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
140 RASH 4 0.0000
141 SEIZURE 1 0.0000
142 PALPITATIONS 1 0.0000
143 CHILLS 1 0.0000
144 FEELING ABNORMAL 2 0.0000
145 OEDEMA PERIPHERAL 1 0.0000
146 DIZZINESS 4 0.0000
147 PRURITUS 3 0.0000
148 RENAL FAILURE 1 0.0000
149 NEUTROPENIA 1 0.0000
150 VISION BLURRED 1 0.0000
151 INFECTION 1 0.0000
152 FATIGUE 5 0.0000
153 PARAESTHESIA 1 0.0000
154 COVID-19 1 0.0000
155 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
156 DYSPNOEA 3 0.0000
157 ANAEMIA 1 0.0000
158 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
159 HEADACHE 3 0.0000
160 DEPRESSION 1 0.0000
161 DECREASED APPETITE 1 0.0000
162 COUGH 1 0.0000
163 OFF LABEL USE 3 0.0000
164 MALAISE 1 0.0000